These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 694846)

  • 21. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
    Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
    ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.
    Holmer E; Kurachi K; Söderström G
    Biochem J; 1981 Feb; 193(2):395-400. PubMed ID: 6914196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dansyl (5-dimethylaminonaphthalene-1-sulphonyl)-heparin binds antithrombin III and platelet factor 4 at separate sites.
    Piepkorn MW
    Biochem J; 1981 May; 196(2):649-51. PubMed ID: 7317004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunoassay of human platelet factor 4(PF4, antiheparin factor) by radial immunodiffusion.
    Niewiarowski S; Lowery CT; Hawiger J; Millman M; Timmons S
    J Lab Clin Med; 1976 Apr; 87(4):720-33. PubMed ID: 818325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of heparin, NaCl and CaCl2 on the rate of the thrombin-antithrombin III reaction.
    Machovich R; Regoeczi E; Hatton MW
    Thromb Res; 1979; 15(5-6):821-34. PubMed ID: 494181
    [No Abstract]   [Full Text] [Related]  

  • 28. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.
    Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE
    J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anticoagulant effect of heparin + antithrombin III using purified fibrinogen as substrate.
    Andersen P; Godal HC
    Haemostasis; 1977; 6(6):329-38. PubMed ID: 611046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HEPARIN, PROTAMINE AND POLYBRENE. THEIR EFFECT UPON CERTAIN COAGULATION FACTORS AFTER INCUBATION WITH PLASMA.
    BRITTEN A
    Thromb Diath Haemorrh; 1965 Jun; 13():550-60. PubMed ID: 14347876
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of platelet factor 4 on the neutralization of heparin by protamine.
    Shanberge JN; Quattrociocchi-Longe TM
    Ann N Y Acad Sci; 1989; 556():354-65. PubMed ID: 2735664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of the antithrombin III-heparin-thrombin complex in the defense reaction of the anticoagulation system].
    Kudriashov BA; Liapina LA; Pastorova VE
    Vopr Med Khim; 1988; 34(2):38-42. PubMed ID: 3400189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of heparin, protamine and polybrene on the time integral of thrombin generation (endogenous thrombin potential).
    Rotteveel RC; Roozendaal KJ; Weijers RN; Eijsman L
    Haemostasis; 1996; 26(1):1-10. PubMed ID: 8698272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4).
    Padilla A; Gray E; Pepper DS; Barrowcliffe TW
    Br J Haematol; 1992 Oct; 82(2):406-13. PubMed ID: 1329921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of platelet-derived β-thromboglobulins on coagulation.
    Egan K; van Geffen JP; Ma H; Kevane B; Lennon A; Allen S; Neary E; Parsons M; Maguire P; Wynne K; O' Kennedy R; Heemskerk JWM; Áinle FN
    Thromb Res; 2017 Jun; 154():7-15. PubMed ID: 28384443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antiheparin effect of alpha1-acid glycoprotein and platelet material, evaluated by the heparin thrombin clotting time.
    Andersen P; Godal HC
    Haemostasis; 1977; 6(6):339-46. PubMed ID: 611047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.
    Matsuo T; Matsuo M; Sugimoto T; Wanaka K
    Pathophysiol Haemost Thromb; 2007; 36(6):305-10. PubMed ID: 20224256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet factor 4 does not promote von Willebrand factor binding to human platelets.
    Levine SP; Moake JL
    Thromb Res; 1984 Nov; 36(3):233-43. PubMed ID: 6440307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter: Heparin thrombin clotting-time and platelet factor 4.
    O'Brien JR; Etherington M; Jamieson S; Lawford P
    Lancet; 1974 Sep; 2(7881):656-7. PubMed ID: 4137779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.